Search

We describe a novel bioflocculant, MBF-15, which is an exopolysaccharide extracted from the alkaliphilic bacterium Paenibacillus jamilae. The biophysical characteristics of MBF-15 were determined using Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy. MBF-15 was also evaluated for its biocompatibility by examining its inflammatory, coagulant, and hemostatic properties in vitro and in vivo. Pretreatment of peripheral blood mononuclear cells with MBF-15 inhibited lipopolysaccharide-stimulated expression of inducible nitric oxide synthase, production of nitric oxide, and secretion of pro-inflammatory cytokines, including tumor necrosis factor-α and interleukin-6. In addition, MBF-15 increased both mRNA and protein levels of the anti-inflammatory cytokines transforming growth factor-β and IL-10. The hemocompatibility of MBF-15 was investigated by measuring the hemolysis ratio and clotting times. MBF-15 had high pro-thrombogenic activity but was not hemolytic. In a rat model, MBF-15 showed superior hemostatic properties compared with chitosan. Thus, MBF-15 offers a promising combination of anti-inflammatory and pro-coagulant properties that may be useful for hemostasis in a variety of clinical settings. [ABSTRACT FROM AUTHOR]

Bioflocculants are widely used in a large variety of applications, because of their wide range of flocculation. There is limited information in the literature about the ability of bioflocculants to perform beneficial functions without having adverse effects on blood components. In this study, general hemocompatibility of a bioflocculant (MBF-06) was investigated in an in vitro system, measuring flocculation of plasma proteins, red blood cell integrity, blood cell counts, platelet activation, clot formation, complement activation, cytotoxicity and inflammatory response. Effects of MBF-06 included low plasma protein flocculation, low platelet activation, low inflammatory response, no hemolysis or cytotoxicity and increased expression of coagulation markers, including prothrombin fragments 1 + 2. These findings suggested that the rapid hemostasis caused by MBF-06 resulted, essentially, from humoral coagulation. Overall, our observations revealed the great potential of MBF-06 as a novel hemostatic agent. [ABSTRACT FROM AUTHOR]

A novel strain (designated as ZCY-7) which could convert H-acid into bioflocculants was isolated from H-acid wastewater sludge. Conditions for bioflocculants production were optimized by response surface methodology (RSM) and determined to be inoculum size 9.65%, initial pH 7.0, and COD Cr of the H-acid wastewater 520 mg/L. The highest flocculating efficiency achieved for kaolin suspension was 95.1%, after 60 h cultivation. The yielded bioflocculant was mainly composed of polysaccharide (82.4%) and protein (14.2%), and maintained its flocculating activity in 0.4% (w/w) kaolin suspensions over pH 2–8 and 20–80 °C. Fourier transform infrared (FTIR) spectra showed that amino, amide and hydroxyl groups were present in the bioflocculant molecules. A viable alternative treatment technology of H-acid wastewater using this novel strain is suggested, which could largely reduce bioflocculants costs. In addition, flocculating mechanism investigation reveals that the bioflocculant could cause kaolin suspension instability by means of charge neutralization firstly and then promoted the aggregation of suspension particles by adsorption and bridge. It is evident from the results that H-acid wastewater could be used as a source to manufacture bioflocculants. [ABSTRACT FROM AUTHOR]